Related Experiment Video
Updated: Jun 7, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Discovery and structure-activity relationship study of nicotinamide derivatives as DNA demethylase ALKBH2 inhibitors
Ke Xu1, Feng Li2, Liang Xiong2
1Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, 610041, China.
Abstract:
AlkB homolog 2 (ALKBH2) is a Fe (II) and 2-oxoglutarate (2OG)-dependent DNA demethylase. It has been reported to be highly expressed in many cancers including glioblastoma (GBM) and affected disease progression by regulating gene expression. Small molecule inhibitors of ALKBH2 might be used as disease intervention reagents or chemical tools for bio-functional studies of ALKBH2, but currently no potent and selective ALKBH2 inhibitors are reported. We herein disclose a new potent and selective ALKBH2 inhibitor (AH2-15c), which showed an IC50 value of 0.031 ± 0.001 μM in a fluorescence polarization (FP) assay and exhibited more than 200-fold selectivity towards ALKBH2 versus other AlkB subfamily members. Since AH2-15c showed very low cellular activity due to its poor cell membrane permeability originating from the carboxyl group, we investigated the un-hydrolyzed counterpart AH2-14c. AH2-14c could directly bind to ALKBH2 and increase the abundance of DNA N3-methylcytosine (3meC) modifications in GBM U87 cells, with a superior effect to AH2-15c. In addition, AH2-14c exhibited much better activities of anti-viability, anti-proliferation and anti-migration against U87 cells. Collectively, we discovered the first potent and selective ALKBH2 inhibitor, which could be taken as a foundation for future drug development and mechanism of action studies.
Insights
Researchers developed AH2-14c, the first potent and selective inhibitor targeting AlkB homolog 2 (ALKBH2) DNA demethylase. This compound shows promise for glioblastoma treatment and further research into ALKBH2
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- AlkB homolog 2 (ALKBH2) is an Fe(II) and 2-oxoglutarate (2OG)-dependent DNA demethylase.
- ALKBH2 is highly expressed in cancers like glioblastoma (GBM), influencing disease progression.
- There is a lack of potent and selective ALKBH2 inhibitors for therapeutic or research use.
Purpose of the Study:
- To discover and characterize novel potent and selective inhibitors of ALKBH2.
- To evaluate the potential of these inhibitors as therapeutic agents for glioblastoma.
- To explore the mechanism of action of ALKBH2 inhibition in cancer cells.
Main Methods:
- Synthesis and screening of small molecule inhibitors.
- Fluorescence polarization (FP) assay to determine IC50 values and selectivity.
- Cellular assays to assess anti-viability, anti-proliferation, and anti-migration effects in GBM U87 cells.
Main Results:
- AH2-15c identified as a potent ALKBH2 inhibitor (IC50 = 0.031 μM) with >200-fold selectivity.
- AH2-14c, a cell-permeable derivative, demonstrated superior efficacy in increasing DNA 3meC modifications in GBM U87 cells.
- AH2-14c exhibited significant anti-viability, anti-proliferation, and anti-migration activities in U87 cells.
Conclusions:
- AH2-14c is the first potent and selective ALKBH2 inhibitor with demonstrated cellular activity.
- This inhibitor holds potential as a foundation for developing new glioblastoma therapies.
- Further studies can utilize AH2-14c to investigate ALKBH2's role in cancer biology.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Nucleic Acid Structure
DNA Structure
DNA...
The DNA Helix
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Biosynthesis of Nucleic Acids